The use of Complementary and Alternative Medicines (CAMs) in the treatment of diabetes mellitus: Is continued use safe and effective?

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Medagama, Arjuna B ^a   Bandara, Ruwanthi ^b  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b Peradeniya Teaching Hospital   (Sri Lanka)

Author keywords

Bitter gourd (Momordica charantia); Cinnamomum zeylanicum); Cinnamon (Cinnamomum cassia; Complementary and Alternative Medicine (CAM); Crepe ginger (Costus speciosus); Fenugreek (Trigonella foenum graecum); Ivy gourd (Coccinia grandis); Type 2 diabetes mellitus

Indexed keywords

BIGUANIDE; CINNAMON EXTRACT; COSTUNOLIDE; FENUGREEK EXTRACT; GINGER EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HERBACEOUS AGENT; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; METFORMIN; MOMORDICA CHARANTIA EXTRACT; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLACEBO; PYRUVATE KINASE; RIBOFLAVIN; SULFONYLUREA; ANTIDIABETIC AGENT; FENUGREEK SEED MEAL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ALTERNATIVE MEDICINE; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; AUSTRALIA; BLOATING; CINNAMON; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG SAFETY; DRUG SYNTHESIS; DRUG USE; DYSPEPSIA; ENZYME INHIBITION; FENUGREEK; FLATULENCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIC COMA; HYPOKALEMIA; MICTURITION DISORDER; MOMORDICA CHARANTIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RASH; REVIEW; SEIZURE; UNITED KINGDOM; URTICARIA; ANIMAL; CHEMISTRY; CINNAMOMUM ZEYLANICUM; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; PHYTOTHERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIGONELLA;

ANIMALS; CINNAMOMUM ZEYLANICUM; COMPLEMENTARY THERAPIES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; HYPOGLYCEMIC AGENTS; MOMORDICA CHARANTIA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGONELLA;

EID: 84924968056     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-102     Document Type: Review

References (66)

1. World Health Organization: WHO Diabetes Fact Sheet No 312. available at www.who.int/mediacentre/factsheets. 2013 October.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
3. Kumar D, Bajaj S, Mehrotra R: Knowledge, attitude and practice of complementary and alternative medicines for diabetes. Public Health 2006, 120(8):705-711.
4. Vuksan V, Sievenpiper JL, Koo VY, Francis JL: American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000, 160(7):1009-1013.
5. Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas Gunawardana N, Katulanda P: Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 2012, 29(12):1480-1492.
6. Oubre AY, Carlson TJ, King SR, Reaven GM: From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia 1997, 40(5):614-617.
7. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC: Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med 2013, 2013:378657.
8. Bell RA, Suerken CK, Gryzwacz JG, Quandt SA, Arcury TA: Complimentary and alternative medicine use among adults with diabetes in the United Sates. Altern Ther Health Med 2006, 12(5):16-22.
9. Garrow D, Egede LE: Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. Diabetes Care 2006, 29(1):15-19.
10. Kristoffersen SS, Atkin PA, Shenfield GM: Uptake of alternative medicine (Letter). Lancet 1996, 347(9006):972.
11. Thomas KJ, Nicholl JP, Coleman P: Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001, 9(1):2-11.
12. Manya K, Champion B, Dunning T: The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med 2012, 12:2.
13. Jayaprakasha GK, Rao LJ: Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr 2011, 51(6):547-562.
14. Rafehi H, Ververis K, Karagiannis TC: Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes Obes Metab 2012, 14(6):493-499.
15. Brahmachari S, Jana A, Pahan K: Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 2009, 183(9):5917-5927.
16. Aggarwal BB: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 2010, 30:173-199.
17. Choi K, Kim YB: Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 2010, 25(2):119-129.
18. Cao H, Polansky MM, Anderson RA: Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 2007, 459(2):214-222.
19. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y: Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 2003, 62(3):139-148.
20. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ: Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 2004, 52(1):65-70.
21. Sheng XZY, Gong Z, Huang C, Zang YQ: Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res 2008, 581348:9.
22. Adisakwattana SLO, Poputtachai U, Minipun A, Suparpprom C: Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Plant Foods Hum Nutr 2011, 66:143-148.
23. Anand P, M K, Tandon V, Murthy PS, Chandra R: Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chemico-Biolog Interact 2010, 186:72-81.
24. Hlebowicz JDJ, Bjorgell O, Almer LO: effect of cinnamon on post prandial blood glucose, gastric emptying and and satiety in healthy subjects. Am J Clin Nutr 2007, 85(6):969-976.
25. Suppapitiporn SKN, Suppapitiporn S: The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc Thai 2006, 89(Suppl 3):S200-S205.
26. Vanschoonbeek KTB, Senden JM, Wodzig WK, Van Loon LJ: Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr 2006, 136:977-980.
27. Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH, Aston CE: Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care 2007, 30(9):2236-2237.
28. Crawford P: Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009, 22(5):507-512.
29. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA: Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003, 26(12):3215-3218.
30. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, Hahn A: Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006, 36(5):340-344.
31. Akilen R, Tsiami A, Devendra D, Robinson N: Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med 2010, 27(10):1159-1167.
32. Khan RKZ, Shah S: Cinnamon may reduce glucose, lipid and cholesterol level in type 2 diabetic individuals. Pakistan. J Nutr 2010, 9(5):430-433.
33. Leach MJ, Kumar S: Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 2012, 9:CD007170.
34. Yan Hong W, Avula B, Dhammika Nanayakkara NP†, Jianping Z†, Khan Ikhlas A: Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the united state. J Agric Food Chem 2013, 61(18):4470-4476.
35. Abraham K, Wohrlin F, Lindtner O, Heinemeyer G, Lampen A: Toxicology and risk assessment of coumarin: focus on human data. Mol Nutr Food Res 2010, 54(2):228-239.
36. Association EFS: Coumarin in flavourings and other food ingredients with flavouring properties. EFSA J 2008, 793:1-15.
37. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA: Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 2006, 3:45-53.
38. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA: Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 2009, 28(1):16-21.
39. Grover JK, Yadav SP: Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004, 93(1):123-132.
40. Basch E, Gabardi S, Ulbricht C: Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm 2003, 60(4):356-359.
41. Zhu Y, Dong Y, Qian X, Cui F, Guo Q, Zhou X, Wang Y, Zhang Y, Xiong Z: Effect of superfine grinding on antidiabetic activity of bitter melon powder. Int J Mol Sci 2012, 13(11):14203-14218.
42. Ahmed I, Lakhani MS, Gillett M, John A, Raza H: Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordicacharantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2001, 51:155-161.
43. Yibchok-anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH: Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull 2006, 29(6):1126-1131.
44. John AJ, Cherian R, Subhash HS, Cherian AM: Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent-a randomized controlled clinical trial. Indian J Physiol Pharmacol 2003, 47(3):363-365.
45. Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, Velez GG: The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol 2007, 60(6):554-559.
46. Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines P: Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol 2011, 134(2):422-428.
47. Ahmad N, Hassan MR, Halder H, Bennoor KS: Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med Res Counc Bull 1999, 25(1):11-13.
48. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS: Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986, 17(3):277-282.
49. Haber SL, Keonavong J: Fenugreek use in patients with diabetes mellitus. Am J Health-Sysyt Pharm 2013, 70:1198-2013.
50. Vijaykumar MV, Singh S, Chhipa RR, Chhipa RR, Bhat MK: The hypoglycaemic activit of of fenugreek seed extract is mediated through the stimulation of an insulin signaling pathway. Br J Pharmcol 2005, 146:41-48.
51. Mohammad S, Taha A, Akhtar K, Bamezai RN, Baquer NZ: In vivo effect of Trigonella foenum graecum on the expression of pyruvate kinase, phosphoenolpyruvate carboxykinase, and distribution of glucose transporter (GLUT4) in alloxan-diabetic rats. Can J Physiol Pharmacol 2006, 84(6):647-654.
52. Madar Z, Abel R, Samish S, Arad J: Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr 1988, 42(1):51-54.
53. Gupta A, Gupta R, Lal B: Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India 2001, 49:1057-1061.
54. Lu FR, Shen L, Qin Y, Gao L, Li H, Dai Y: Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus. Chin J Integr Med 2008, 14(1):56-60.
55. Kassaian N, Azadbakht L, Forghani B, Amini M: Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res 2009, 79(1):34-39.
56. Bavarva JH, Narasimhacharya AV: Antihyperglycemic and hypolipidemic effects of Costus speciosus in alloxan induced diabetic rats. Phytother Res 2008, 22(5):620-626.
57. Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V: Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats. Chem Biol Interact 2009, 179(2-3):329-334.
58. Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V: Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats. Chem Biol Interact 2009, 182(1):67-72.
59. Kuriyan R, Rajendran R, Bantwal G, Kurpad AV: Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care 2008, 31(2):216-220.
60. Kamble SM, Kamlakar PL, Vaidya S, Bambole VD: Influence of Coccinia indica on certain enzymes in glycolytic and lipolytic pathway in human diabetes. Indian J Med Sci 1998, 52(4):143-146.
61. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K: Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 2002, 25(1):81-86.
62. Shibib BA, Amin MA, Hassa AK, Rahman R: A creeper, Coccinia indica, has anti-hyperglycaemic and anti-ureogenic effects in diabetic rats. J Pak Med Assoc 2012, 62(11):1145-1148.
63. Manjula S, Ragavan B: Hypoglycemic and Hypolipidemic effect of Coccinia indica Wight & Arn in alloxan induced diabetic rats. Anc Sci Life 2007, 27(2):34-37.
64. Krishnakumari S, Bhuvaneswari P, Rajeswari P: Ameliorative potential of Coccinia grandis extract on serum and liver marker enzymes and lipid profile in streptozotocin induced diabetic rats. Anc Sci Life 2011, 31(1):26-30.
65. Khan AK, AKhtar S, Mahta H: Treatment of diabetes mellitus with Coccinia indica. Br Med J 1980, 280(6220):1044.
66. Munasinghe MA, Abeysena C, Yaddehige IS, Vidanapathirana T, Piyumal KP: Blood sugar lowering effect of Coccinia grandis (L.) J. Voigt: path for a new drug for diabetes mellitus. Exp Diabetes Res 2011, 2011:978762.